Novartis Institutes for BioMedical Research, Inc.'s Net Worth

$92.9 Million

Estimate Recalculated Nov 1, 2024 04:20AM EST

Who is Novartis Institutes for BioMedical Research, Inc.?

Novartis Institutes for BioMedical Research, Inc. has an estimated net worth of $92.9 Million. This is based on reported shares across multiple companies, which include Surface Oncology, Inc., Homology Medicines, Inc., and Intellia Therapeutics, Inc..

SEC CIK

Novartis Institutes for BioMedical Research, Inc.'s CIK is 0001673852

Past Insider Trading and Trends

2016 was Novartis Institutes for BioMedical Research, Inc.'s most active year for acquiring shares with 4 total transactions. Novartis Institutes for BioMedical Research, Inc.'s most active month to acquire stocks was the month of March. 2016 was Novartis Institutes for BioMedical Research, Inc.'s most active year for disposing of shares, totalling 3 transactions. Novartis Institutes for BioMedical Research, Inc.'s most active month to dispose stocks was the month of March. 2018 saw Novartis Institutes for BioMedical Research, Inc. paying a total of $11,499,990.00 for 5,927,708 shares, this is the most they've acquired in one year. In 2017 Novartis Institutes for BioMedical Research, Inc. cashed out on 1,523,000 shares for a total of $27,870,900.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Surface Oncology, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
3.95M
$15.00
—
3.95M
Apr 23
Form 3
—
0
—
—
0
No matching records found

Homology Medicines, Inc. (FIXX) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.98M
—
—
1.98M
Apr 2
Form 3
—
0
—
—
0
No matching records found

Intellia Therapeutics, Inc. (NTLA) Snapshot price: $19.75

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
Form 4
-26.94%
-1.52M
$18.30
-$27,870,900.00
4.13M
Dec 12
Form 4
+1.42%
79.25K
—
—
5.65M
Mar 3
Form 4
∞
5.57M
$18.00
—
5.57M
May 11
Form 3
—
0
—
—
0
No matching records found